TEL AVIV, Israel — Kamedis Inc., in collaboration with Taro Pharmaceutical Industries Ltd., has launched the Kamedis Bio-Herbal Dandruff Care system.

A global provider of clinically proven skin care products, Kamedis said the solution — comprising a scalp lotion and a dandruff shampoo — is the world’s first therapeutic two-step system to fight dandruff and seborrheic dermatitis. The product is available at Walgreens drug stores nationwide, as well as at select retailers.

Both the scalp lotion and shampoo in the Kamedis Bio-Herbal Dandruff Care system are infused with Botaniplex, a combination of botanical concentrates and clinically proven active ingredients that reduce scaling and treat the itching at the source while nourishing and hydrating the scalp, according to the company.

“To create a dandruff product that is both effective and gentle on the hair and scalp, we collaborated with a team of dermatologists and researchers who are experts in botanical chemistry. The end result is this new holistic approach to treating dandruff using a two-step regimen that is based on natural ingredients,” stated Roni Kramer, chairperson and chief executive officer of Kamedis. “Our philosophies and therapeutic approach to developing botanically-based, clinically proven products will continue to align with the growing consumer demand for natural skin care solutions.”

Botaniplex fights dandruff in two ways, Kamedis noted. The active ingredient, pyrithione zinc, kills the fungus that is behind many cases of dandruff and seborrheic dermatitis, and the botanical concentrates soothe, hydrate and nourish the hair and scalp, relieving the common symptoms of dandruff.

The formulation is also free of parabens, steroids and sodium lauryl sulfates (SLS), making the system gentle on the scalp and safe to use on color-treated hair, Kamedis said.

“We are pleased to collaborate with Kamedis to bring a quality product for dandruff and seborrheic dermatitis — backed by scientific innovation — to consumers in the United States,” commented John Francis, vice president of OTC sales and marketing at Taro. “As a leading manufacturer and supplier of topical dermatological products, we are committed to delivering meaningful brands that millions of Americans can rely upon.”

Dandruff is the most common scalp disorder in adolescence and adulthood, affecting more than 50 million people in United States, Kamedis reported.